SCHMC

Study design and rationale of the 'Balloon-Expandable Cobalt Chromium SCUBA Stent versus Self-Expandable COMPLETE-SE Nitinol Stent for the Atherosclerotic ILIAC Arterial Disease (SENS-ILIAC Trial) Trial': study protocol for a randomized controlled trial

Metadata Downloads
Abstract
BACKGROUND: The self-expandable COMPLETE™ stent (Medtronic) has greater elasticity, allowing it to regain its shape after the compression force reduces, and has higher trackability, thus is easier to maneuver through tortuous vessels, whereas the balloon-expandable SCUBA™ stent (Medtronic) has higher radial stiffness and can afford more accurate placement without geographic miss, which is important in aortoiliac bifurcation lesions. To date, there have been no randomized control trials comparing efficacy and safety between the self-expanding stent and balloon-expandable stent in advanced atherosclerotic iliac artery disease. METHODS/DESIGN: The purpose of our study is to examine primary patency (efficacy) and incidence of stent fracture and geographic miss (safety) between two different major representative stents, the self-expanding nitinol stent (COMPLETE-SE™) and the balloon-expanding cobalt-chromium stent (SCUBA™), in stenotic or occlusive iliac arterial lesions. This trial is designed as a prospective, randomized, multicenter trial to demonstrate a noninferiority of SCUBA™ stent to COMPLETE-SE™ stent following balloon angioplasty in iliac arterial lesions, and a total of 280 patients will be enrolled. The primary end point of this study is the rate of primary patency in the treated segment at 12months after intervention as determined by catheter angiography, computed tomography angiography, or duplex ultrasound. DISCUSSION: The SENS-ILIAC trial will give powerful insight into whether the stent choice according to deployment mechanics would impact stent patency, geographic miss, or stent fracture in patients undergoing stent implantation in iliac artery lesions. TRIAL REGISTRATION: National Institutes of Health Clinical Trials Registry (ClinicalTrials.gov identifier: NCT01834495 ), registration date: May 8, 2012.
All Author(s)
W. G. Choi ; S. W. Rha ; C. U. Choi ; E. J. Kim ; D. J. Oh ; Y. H. Cho ; S. H. Park ; S. J. Lee ; A. Y. Hur ; Y. G. Ko ; S. M. Park ; K. C. Kim ; J. H. Kim ; M. W. Kim ; S. M. Kim ; J. H. Bae ; J. M. Bong ; W. Y. Kang ; J. B. Seo ; W. Y. Jung ; J. H. Cho ; H. Kim do ; J. H. Ahn ; S. H. Kim ; J. Y. Jang
Issued Date
2016
Type
Article
Publisher
BioMed Central
ISSN
1745-6215
Citation Title
Trials
Citation Volume
17
Citation Start Page
302
Citation End Page
302
Language(ISO)
eng
DOI
10.1186/s13063-016-1435-9
URI
http://schca-ir.schmc.ac.kr/handle/2022.oak/1928
Appears in Collections:
심장내과 > 1. Journal Papers
공개 및 라이선스
  • 공개 구분공개
파일 목록

Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.